CD4 and neoplasm: Also, high levels of RANK and RANKL were found in the tumor samples and correlated with lower disease-free survival, while the T cells markers (CD4+ and CD8+) and the immune checkpoint PD-1/PD-L1 were poorly detected in the samples.